| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.00▲ | 1.99▲ | 1.98▲ | 1.91▲ | 1.90▲ |
| MA10 | 2.00▲ | 1.98▲ | 1.98▲ | 1.87▲ | 2.18▼ |
| MA20 | 1.99▲ | 1.97▲ | 1.93▲ | 1.88▲ | 2.62▼ |
| MA50 | 1.97▲ | 1.91▲ | 1.87▲ | 2.25▼ | 2.63▼ |
| MA100 | 1.97▲ | 1.87▲ | 1.84▲ | 2.74▼ | 4.22▼ |
| MA200 | 1.92▲ | 1.83▲ | 1.98▲ | 2.67▼ | 8.25▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.000▼ | 0.004▲ | 0.043▲ | -0.102▼ |
| RSI | 62.216▲ | 66.383▲ | 64.913▲ | 50.294▲ | 43.417▼ |
| STOCH | 85.256▲ | 84.630▲ | 76.765 | 61.629 | 17.290▼ |
| WILL %R | -25.000 | -18.750▲ | -9.375▲ | -4.054▲ | -71.160 |
| CCI | 109.962▲ | 198.551▲ | 152.354▲ | 153.852▲ | -90.092 |
| RSI | $ANVS RSI(14) Crossed Above 50 | Set Alert |
|
Thursday, April 02, 2026 12:29 AM
MALVERN, Pa., April 02, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy ...
|
|
Tuesday, March 03, 2026 12:00 AM
MALVERN, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy ...
|
|
Monday, December 08, 2025 03:50 AM
Novartis AG (NYSE:NVS) is one of the Most Undervalued Stocks to Buy Right Now. On November 24, the company announced that the US FDA approved Itvisma ® (onasemnogene abeparvovec-brve) for treating ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/26 | 1.98 | 2.02 | 1.94 | 2.005 | 701,280 |
| 30/04/26 | 1.94 | 1.9999 | 1.86 | 1.97 | 1,098,120 |
| 29/04/26 | 1.90 | 1.90 | 1.79 | 1.84 | 653,023 |
| 28/04/26 | 1.89 | 2.005 | 1.85 | 1.85 | 1,330,004 |
| 27/04/26 | 1.78 | 1.935 | 1.75 | 1.89 | 1,022,138 |
| 24/04/26 | 1.73 | 1.82 | 1.73 | 1.74 | 856,181 |
| 23/04/26 | 1.82 | 1.8393 | 1.7301 | 1.81 | 1,119,084 |
| 22/04/26 | 1.89 | 1.9099 | 1.81 | 1.84 | 810,867 |
| 21/04/26 | 1.90 | 1.97 | 1.85 | 1.86 | 901,886 |
| 20/04/26 | 1.86 | 1.95 | 1.81 | 1.92 | 894,217 |
|
|
||||
|
|
||||
|
|